Research and Development
Chiron's roots are in pioneering research in infectious diseases, including the first sequencing of the HIV-1 genome, development of HBV vaccine and discovery of the hepatitis C virus. The Chiron business unit's efforts continue to be focused on ensuring a safer blood supply. Novartis makes a significant investment in research and development to bring you exciting, innovative new products to protect health, cure disease and improve well-being.
Thailand Study Affirms Value of Nucleic Acid Testing in Developing World
A study recently conducted by researchers from Chiron and Chiang Mai University Hospital in Thailand highlighted the value of using the PROCLEIX® ULTRIO® Assay in the conditions most common throughout rural Asia.
Learn more »
A Milestone for Diagnostics R&D*
With the successful closure of Phase II on November 28, 2006, Diagnostics R&D has moved a crucial step forward in the development of a new product, and also closer to a significant organizational milestone. Learn more »
Product Pipeline
Chiron scientists and collaborators are working on new blood screening assays and a system to help blood centers deal with shortages of type O blood.
Learn More »